相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel Targeted Therapeutic Strategies for Ewing Sarcoma
Daria Fayzullina et al.
CANCERS (2022)
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Jana Koch et al.
NATURE COMMUNICATIONS (2022)
Ewing's Sarcoma
Nicolo Riggi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The translational repressor 4E-BP1 regulates RRM2 levels and functions as a tumor suppressor in Ewing sarcoma tumors
Kelli L. Goss et al.
ONCOGENE (2021)
Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
Oxana Schmidt et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Sarcoma IL-12 overexpression facilitates NK cell immunomodulation
Mary Jo Rademacher et al.
SCIENTIFIC REPORTS (2021)
TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma
Bo Kyung A. Seong et al.
CANCER CELL (2021)
Therapeutic Potential of EWSR1-FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma
Saint T. Cervera et al.
CANCERS (2021)
Viral vector platforms within the gene therapy landscape
Jote T. Bulcha et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Management of recurrent Ewing sarcoma: challenges and approaches
David Van Mater et al.
ONCOTARGETS AND THERAPY (2019)
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation
Alessandra De Feo et al.
CELL DEATH & DISEASE (2019)
EWS-FLI1-mediated tenascin-C expression promotes tumour progression by targeting MALAT1 through integrin α5β1-mediated YAP activation in Ewing sarcoma
Shaohui He et al.
BRITISH JOURNAL OF CANCER (2019)
Autophagy and doxorubicin resistance in cancer
Chao Chen et al.
ANTI-CANCER DRUGS (2018)
Off-target predictions in CRISPR-Cas9 gene editing using deep learning
Jiecong Lin et al.
BIOINFORMATICS (2018)
EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins
Paradesi Naidu Gollavilli et al.
CANCER RESEARCH (2018)
Recombinant Adenovirus-p53 Gene Therapy for Advanced Unresectable Soft-Tissue Sarcomas
Shao-wen Xiao et al.
HUMAN GENE THERAPY (2018)
Target discovery screens using pooled shRNA libraries and next-generation sequencing: A model workflow and analytical algorithm
Christiane Schaefer et al.
PLOS ONE (2018)
Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs
Jennifer Listgarten et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced Mucositis
Michael Thomsen et al.
INTEGRATIVE CANCER THERAPIES (2018)
Genome-scale CRI SPR-Cas9 screen identifies druggable dependencies in TP53 wild-type Ewing sarcoma
Bjorn Stolte et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9
Raul Torres-Ruiz et al.
STEM CELL REPORTS (2017)
Protective effects of kaempferol against reactive oxygen species-induced hemolysis and its antiproliferative activity on human cancer cells
Wenzhen Liao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Association of genetic variants in the 3'UTR of HLA-G with Recurrent Pregnancy Loss
Giada Amodio et al.
HUMAN IMMUNOLOGY (2016)
Origins of Programmable Nucleases for Genome Engineering
Srinivasan Chandrasegaran et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Cadherin-11 regulates the metastasis of Ewing sarcoma cells to bone
Mihoko Hatano et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Non-viral vectors for gene-based therapy
Hao Yin et al.
NATURE REVIEWS GENETICS (2014)
Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system
R. Torres et al.
NATURE COMMUNICATIONS (2014)
High-Throughput Tyrosine Kinase Activity Profiling Identifies FAK as a Candidate Therapeutic Target in Ewing Sarcoma
Brian D. Crompton et al.
CANCER RESEARCH (2013)
One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
Haoyi Wang et al.
CELL (2013)
Cancer translocations in human cells induced by zinc finger and TALE nucleases
Marion Piganeau et al.
GENOME RESEARCH (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
Gaelle Picarda et al.
JOURNAL OF BONE ONCOLOGY (2013)
Clinical Features and Outcomes in Patients with Extraskeletal Ewing Sarcoma
Mark A. Applebaum et al.
CANCER (2011)
Modeling Initiation of Ewing Sarcoma in Human Neural Crest Cells
Cornelia von Levetzow et al.
PLOS ONE (2011)
Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival
Gaelle Picarda et al.
CLINICAL CANCER RESEARCH (2010)
Murine Bone Marrow-derived Mesenchymal Stem Cells as Vehicles for Interleukin-12 Gene Delivery Into Ewing Sarcoma Tumors
Xiaoping Duan et al.
CANCER (2009)
Ewing Sarcoma Demonstrates Racial Disparities in Incidence-related and Sex-related Differences in Outcome An Analysis of 1631 Cases From the SEER Database, 1973-2005
Muhammad U. Jawad et al.
CANCER (2009)
Advances in Ewing's Sarcoma Research: Where Are We Now and What Lies Ahead?
Jose Luis Ordonez et al.
CANCER RESEARCH (2009)
Analysis of Lentiviral Vector Integration in HIV plus Study Subjects Receiving Autologous Infusions of Gene Modified CD4+T Cells
Gary P. Wang et al.
MOLECULAR THERAPY (2009)
Doxorubicin augments rAAV-2 transduction in rat neuronal cells
Ting Zhang et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
A Molecular Function Map of Ewing's Sarcoma
Maximilian Kauer et al.
PLOS ONE (2009)
GLI1 Is a Central Mediator of EWS/FLI1 Signaling in Ewing Tumors
Jay Joo et al.
PLOS ONE (2009)
Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma
Hui Guan et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging
Amin Hajitou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The EWS/FLI1 oncogenic transcription factor deregulates GLI1
J. P. Zwerner et al.
ONCOGENE (2008)
Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma
S Hu-Lieskovan et al.
CANCER RESEARCH (2005)
E1A specifically enhances sensitivity to topoisomerase IIα targeting anticancer drug by up-regulating the promoter activity
ZC Zhou et al.
MOLECULAR CANCER RESEARCH (2005)
Suicide gene therapy of sarcoma cell lines using recombinant adeno-associated virus 2 vectors
MR Veldwijk et al.
CANCER GENE THERAPY (2004)
High-level expression of the coxsackievirus and adenovirus receptor messenger RNA in osteosarcoma, Ewing's sarcoma, and benign neurogenic tumors among musculoskeletal tumors
WG Gu et al.
CLINICAL CANCER RESEARCH (2004)
Ewing sarcoma family of tumors express adenovirus receptors and are susceptible to adenovirus-mediated oncolysis
AM Rice et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2002)
Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids
M Athanasiou et al.
CANCER GENE THERAPY (2000)
An adeno-associated virus (AAV) initiator protein, Rep78, catalyzes the cleavage and ligation of single-stranded AAV ori DNA
RH Smith et al.
JOURNAL OF VIROLOGY (2000)
分享论文
